Basic Information
ARTIDIS, based on nano-cancer biomarkers, enables rapid cancer diagnosis, detects its invasiveness, and predicts the likelihood of metastasis in patients. The ARTIDISNET platform integrates nanomechanical biomarkers with patients' clinical data to guide the optimal treatment choice for each patient.
ARTIDIS AG
Basel,CantonofBasel-City,Switzerland
15~50 people
January 01, 2017
info@artidis.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios